Cargando…
Enhancing the efficacy of cisplatin in ovarian cancer treatment – could arsenic have a role
Ovarian cancer affects more than 200,000 women each year around the world. Most women are not diagnosed until the disease has already metastasized from the ovaries with a resultant poor prognosis. Ovarian cancer is associated with an overall 5 year survival of little more than 50%. The mainstay of f...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2636805/ https://www.ncbi.nlm.nih.gov/pubmed/19144189 http://dx.doi.org/10.1186/1757-2215-2-2 |